Pingping He

Pingping He

Auto-generated profile, based on publicly available information

Pingping He

P53 Laboratory, A*Star, Singapore

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2013 in Journal of Epidemiology and Community Health
Verified
Journal Article
Open access
JLJun Lv
Jun Lv
QLQing-Min Liu
Qing-Min Liu
Yanjun RenYanjun Ren
Yanjun Ren
PHPing-Ping He
Ping-Ping He
SWShengfeng Wang
Shengfeng Wang
OCon behalf of the Community Interventions for Health (CIH) collaboration
on behalf of the Community Interventions for Health (CIH) collaboration
Background: To assess the short-term impact of a comprehensive, community-based multilevel intervention on knowledge, beliefs and practices with respect to smoking, physical activity and diet in Hangzhou, China. Methods: A non-randomised, controlled, before-after quasi-experimental trial was conducted in two intervention areas and one comparison area. The intervention built on a socioecological framework and took place across four settings: neighbourhoods, schools, workplaces and community health centres. Two independent cross-sectional surveys of adults aged 18–64 years at baseline and a subsequent follow-up were conducted in 2008/2009 and 2011 in the intervention and comparison areas. A 2-year intervention programme was begun in mid-2009 and continued until mid-2011. Results: A total of 2016 adults at baseline and 2016 adults at follow-up completed the survey. Over the 2-year intervention period, the intervention areas showed a statistically significant decline (25.2% vs 18.7%, p<0.001) in the prevalence of smoking compared with the comparison area (18.0% vs 16.4%, p=0.343). The proportion of individuals who had noticed anyone smoking in any of nine locations in the previous 30 days demonstrated a statistically significant decline in the intervention (78.9% vs 66.5%, p<0.001) and comparison (76.3% vs 66.5%, p<0.001) areas. The fruit and vegetable consumption score increased in a statistically significant manner in the intervention (24.84 vs 25.97, p=0.036) and comparison (24.25 vs 26.67, p<0.001) areas. The metabolic equivalent of physical activity increased from 1204 to 1386 (p=0.023) in the intervention areas compared with 918 to 924 in the comparison area (p=0.201). Conclusions: After a 2-year intervention, beneficial changes were noted in the intervention areas with respect to smoking and physical activity but not diet. A community-based multilevel intervention programme is feasible in urban China.

15 July 2019 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YXYuezhen Xue
Yuezhen Xue
NBNick Barker
Nick Barker
SHShawn Hoon
Shawn Hoon
PHPingping He
Pingping He
TTTeena Thakur
Teena Thakur
DLDavid Lane
David Lane
P53 protein, activated and stabilized by posttranslational modifications, performs its major functions by inducing DNA repair, cell-cycle arrest, or apoptosis through transcriptional activation. Here, we determined the ability of p53 protein stabilized via proteasome inhibition to perform similar functions as p53 induced by stresses such as DNA damage. Treating mice with the proteasome inhibitor bortezomib stabilized p53 in stem/progenitor cells of the intestine and stomach, in other proliferating tissues, and in intestinal tumors. Robust basal p53 mRNA levels were observed in the same compartments where p53 was stabilized. Spatial activation of p53 target genes in response to bortezomib in the small intestine demonstrated that CDKN1A and BAX were upregulated in the proliferative crypts but not in the differentiated villi of the small intestine; PUMA was specifically activated at the crypt base of p53 wild-type mice. Thus, cellular context determines the p53 transcriptional target selection. p53-dependent apoptosis was induced in Lgr5-expressing stem cells of the small intestine and high p53 transcriptional activity and apoptosis was induced in intestinal adenomas and in xenograft tumors. Bortezomib inhibited the growth of intestinal adenomas and xenograft tumors with wild-type p53, indicating the importance of p53 in the response to proteasome inhibitors in tissue homeostasis and in cancer therapy. Significance: These findings show that bortezomib is less active in p53-defective tumors, yet its success in treating multiple myeloma suggests its use can be extended to p53-proficient solid tumors.

31 March 2023
Verified
Other
Open access
YXYuezhen Xue
Yuezhen Xue
NBNick Barker
Nick Barker
SHShawn Hoon
Shawn Hoon
PHPingping He
Pingping He
TTTeena Thakur
Teena Thakur
DLDavid P. Lane
David P. Lane
P53 is stabilized in the transit amplifying zone of the stomach corpus.

31 March 2023
Verified
Other
Open access
YXYuezhen Xue
Yuezhen Xue
NBNick Barker
Nick Barker
SHShawn Hoon
Shawn Hoon
PHPingping He
Pingping He
TTTeena Thakur
Teena Thakur
DLDavid P. Lane
David P. Lane
Supplementary information contains "Supplementary Materials and Methods" and "Supplementary figure legends".

31 March 2023
Verified
Other
Open access
YXYuezhen Xue
Yuezhen Xue
NBNick Barker
Nick Barker
SHShawn Hoon
Shawn Hoon
PHPingping He
Pingping He
TTTeena Thakur
Teena Thakur
DLDavid P. Lane
David P. Lane
P53 mRNA was not stabilized by bortezomib treatment.

31 March 2023
Verified
Other
Open access
YXYuezhen Xue
Yuezhen Xue
NBNick Barker
Nick Barker
SHShawn Hoon
Shawn Hoon
PHPingping He
Pingping He
TTTeena Thakur
Teena Thakur
DLDavid P. Lane
David P. Lane
Stabilized p53 colocalizes with PCNA in the stomach and colon.